PSA
40
2
KMB
30
2
ADM
33
2
MOS
59
11
MCO
64
3
SO
46
6
FTI
69
3
FRT
50
17
AEE
61
3
HPE
51
-2
GPC
38
3
WMT
67
-3
PVH
37
-3
NTRS
44
7
GE
58
-2
NWS
60
2
EFX
38
3
VMC
35
2
EIX
27
-10
O
20
-8
PSA
40
2
KMB
30
2
ADM
33
2
MOS
59
11
MCO
64
3
SO
46
6
FTI
69
3
FRT
50
17
AEE
61
3
HPE
51
-2
GPC
38
3
WMT
67
-3
PVH
37
-3
NTRS
44
7
GE
58
-2
NWS
60
2
EFX
38
3
VMC
35
2
EIX
27
-10
O
20
-8
Financhill
Back

Intuit Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
45

INTU
Intuit

Last Price:
$613.08
Seasonality Move:
-0.22%
Sell
2

CRNX
Crinetics Pharmaceuticals

Last Price:
$38.95
Seasonality Move:
-6.74%
Sell
45
Intuit (INTU) is a Sell

Is Intuit a Buy, Sell or Hold?

  • The current Intuit [INTU] share price is $613.22. The Score for INTU is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • INTU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $38.98. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

INTU Stock Price Chart

What is Intuit's stock price today?

  • The Intuit share price today is $613.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INTU is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $38.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

INTU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.42 Sell
Relative Strength Index (14 RSI): 39.01 Sell
Chaikin Money Flow: -1228272 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (624.62 - 659.46) Sell
Bollinger Bands (100): (613.37 - 661.61) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.13 Sell
Relative Strength Index (14 RSI): 21.13 Sell
Chaikin Money Flow: -690740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.93 - 57.37) Sell
Bollinger Bands (100): (50.63 - 57.85) Sell

INTU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 623.1 Sell
20-day SMA: 639.58 Sell
50-day SMA: 648.18 Sell
200-day SMA: 632.56 Sell
8-day EMA: 623.96 Sell
20-day EMA: 633.72 Sell
50-day EMA: 639.62 Sell
200-day EMA: 626.62 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.98 Sell
20-day SMA: 51.29 Sell
50-day SMA: 54.96 Sell
200-day SMA: 50.99 Sell
8-day EMA: 46.42 Sell
20-day EMA: 50.33 Sell
50-day EMA: 53.11 Sell
200-day EMA: 49.76 Sell

Intuit Earnings Growth & INTU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.34 per share, an increase this year of $2.45 per share, and an increase next year of $2.79 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Intuit Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):